Beyond PCOS: hormonal determinants of insulin resistance in normal-weight women of reproductive age - a scoping review
DOI:
https://doi.org/10.12775/QS.2026.69.74505Keywords
Insulin Resistance, Polycystic Ovary Syndrome, Body Mass Index, Androgens, AdipokinesAbstract
Background/Purpose: Insulin resistance (IR) in normal-weight women is poorly understood and traditionally associated almost exclusively with polycystic ovary syndrome (PCOS). We aimed to map the available literature on the hormonal determinants of IR in normal-weight women of reproductive age.
Methods: The review is compliant with the PRISMA-ScR (2020) guidelines and the Joanna Briggs Institute methodology. PubMed and the Cochrane Library (March 2026) were searched, intentionally omitting the term "PCOS" from the search strategy to capture evidence relevant to women without this condition. The review included 30 studies (approximately 6,500 participants from 17 countries) covering androgens, adipokines, and other factors. Study quality (Newcastle-Ottawa scale) averaged 7.4 out of 9.
Results: 29 of the 30 studies involved women with PCOS, indicating a narrowly defined research interest in this topic. Classic androgen markers - the free androgen index and sex hormone-binding globulin - lost their predictive value for IR in normal-weight women, unlike at higher body mass index (BMI), suggesting a different pathophysiological mechanism. Various adipokines and adipose tissue hormones maintained their association with IR regardless of BMI. The role of anti-Müllerian hormone remained ambiguous. In one study, thyroid-stimulating hormone emerged as an independent predictor of IR. IR was also observed in control groups without PCOS.
Conclusions: A methodologically robust literature on the determinants of IR in normal-weight women is needed, especially beyond the context of PCOS. Filling this gap could lead to improved diagnosis and treatment in this overlooked population. The current literature is heterogeneous and draws primarily correlational conclusions.
References
1. Gierach M, Gierach J, Junik R. Insulin resistance and thyroid disorders. Endokrynol Pol. 2014;65(1):70–76.
2. Burhans MS, Hagman DK, Kuzma JN, Schmidt KA, Kratz M. Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus. Compr Physiol. 2019;9(1):1–58.
3. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998 May 1;47(5):699–713.
4. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci. 2002 Feb;102(2):151–166.
5. Ferrannini E, Iervasi G, Cobb J, Ndreu R, Nannipieri M. Insulin resistance and normal thyroid hormone levels: prospective study and metabolomic analysis. Am J Physiol Endocrinol Metab. 2017 May 1;312(5):E429–E436.
6. Spira D, Buchmann N, Dörr M, et al. Association of thyroid function with insulin resistance: data from two population-based studies. Eur Thyroid J. 2022 Feb 28;11(2):e210063.
7. Tilg H, Ianiro G, Gasbarrini A, Adolph TE. Adipokines: masterminds of metabolic inflammation. Nat Rev Immunol. 2025 Apr;25(4):250–265.
8. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005 Feb 1;8(1):19–32.
9. Peters MDJ, Marnie C, Tricco AC, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020 Oct;18(10):2119–2126.
10. Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018 Oct 2;169(7):467–473.
11. Lazurova I, Figurova J, Lazurova Z, Dravecka I, Maslankova J, Marekova M. Insulin-like growth factor (IGF) system and hormonal-metabolic profile in women with polycystic ovary syndrome. Bratisl Lek Listy. 2021;122(7):469–473.
12. Yildizhan B, Anik Ilhan G, Pekin T. The impact of insulin resistance on clinical, hormonal, and metabolic parameters in lean women with polycystic ovary syndrome. J Obstet Gynaecol. 2016 Oct;36(7):893–896.
13. Livadas S, Macut D, Bothou C, et al. Insulin resistance, androgens, and lipids are gradually improved in an age-dependent manner in lean women with polycystic ovary syndrome: insights from a large Caucasian cohort. Hormones (Athens). 2020 Dec;19(4):531–539.
14. Chen F, Liao Y, Chen M, et al. Evaluation of the Efficacy of Sex Hormone-Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS. Reprod Sci. 2021 Sep;28(9):2504–2513.
15. Mansour A, Mirahmad M, Mohajeri-Tehrani MR, et al. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population. Sci Rep. 2023 Jun 24;13(1):10269.
16. Wang CC, Chang CJ, Hsu MI. The clinical and biochemical characteristics associated with insulin resistance in non-obese young women. Gynecol Endocrinol. 2016 Sep;32(9):767–771.
17. Reyes-Muñoz E, Ortega-González C, Martínez-Cruz N, et al. Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study. BMJ Open. 2016 Jul 22;6(7):e012107.
18. Vitku J, Varausova A, Skodova T, et al. The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women. Int J Mol Sci. 2024 Sep 7;25(17):9691.
19. Polak AM, Krentowska A, Łebkowska A, et al. The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome. Nutrients. 2020 Sep 10;12(9):2753.
20. Peng Y, Yang H, Song J, et al. Elevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2022;13:845165.
21. Foda AA, Foda EA, El-Said ZH. Serum irisin levels in polycystic ovary syndrome after ovarian drilling. Diabetes Metab Syndr. 2019;13(2):1463–1468.
22. Pratama G, Wiweko B, Asmarinah, et al. Mechanism of elevated LH/FSH ratio in lean PCOS revisited: a path analysis. Sci Rep. 2024 Apr 8;14(1):8229.
23. Abdul-Maksoud RS, Zidan HE, Saleh HS, Amer SA. Visfatin and SREBP-1c mRNA Expressions and Serum Levels Among Egyptian Women with Polycystic Ovary Syndrome. Genet Test Mol Biomarkers. 2020 Jul;24(7):409–419.
24. Sahin Ersoy G, Altun Ensari T, Vatansever D, Emirdar V, Cevik O. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile. Gynecol Endocrinol. 2017 Feb;33(2):119–123.
25. Guvenc Y, Var A, Goker A, Kuscu NK. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome. J Int Med Res. 2016 Aug;44(4):796–805.
26. Lai Y, Chen J, Li L, et al. Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome. Sci Rep. 2016 May 16;6:25934.
27. Li XJ, Wang H, Lu DY, et al. Anti-Müllerian Hormone Accelerates Pathological Process of Insulin Resistance in Polycystic Ovary Syndrome Patients. Horm Metab Res. 2021 Aug;53(8):504–511.
28. Yanachkova V, Stankova T. Abnormally Increased Prolactin Levels in Women with Polycystic Ovarian Syndrome Are Associated with Risk of Obesity, Insulin Resistance and Prediabetes. Int J Mol Sci. 2025 Apr 29;26(9):4239.
29. Li XL, Ji YF, Feng Y, Liu SW. Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators. Gynecol Endocrinol. 2024 Dec;40(1):2312895.
30. Dadachanji R, Patil A, Joshi B, Mukherjee S. Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women. PLoS One. 2021;16(2):e0246862.
31. Šimková M, Vítků J, Kolátorová L, et al. Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS? Physiol Res. 2020 Sep 30;69(Suppl 2):S279–S293.
32. Feng W, Xie X, Su Y, Jin R, Shi W. Relationship of adiponectin, leptin and reproductive endocrine hormones with insulin resistance in polycystic ovary syndrome patients with normal BMI. Gynecol Endocrinol. 2024 Dec;40(1):2439886.
33. Ganie MA, Marwaha RK, Nisar S, et al. Impact of hypovitaminosis D on clinical, hormonal and insulin sensitivity parameters in normal body mass index polycystic ovary syndrome women. J Obstet Gynaecol. 2016 May 18;36(4):508–512.
34. González F, Considine RV, Abdelhadi OA, Acton AJ. Oxidative Stress in Response to Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2019 Nov 1;104(11):5360–5371.
35. Cundubey CR, Cam SD. Serum Phoenixin-14 levels of women with polycystic ovary syndrome increase proportionally with BMI. Eur Rev Med Pharmacol Sci. 2023 Apr;27(8):3519–3525.
36. Fanelli F, Mezzullo M, Belluomo I, et al. Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women. Mol Metab. 2017 May;6(5):406–415.
37. Zhang H, Wang W, Zhao J, et al. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022;13:1085656.
38. Zhang Y, Dou P, Huang N, et al. Effects of body fat percentage on hormonal profiles, metabolism and adipokine-related indicators in PCOS patients with a normal body mass index: A cross-sectional study. J Gynecol Obstet Hum Reprod. 2026 Feb 1;55(2):103099.
39. Dumesic DA, Phan JD, Leung KL, et al. Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2019 Jun 1;104(6):2171–2183.
40. Anik Ilhan G, Yildizhan B, Pekin T. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome. Gynecol Endocrinol. 2019 Mar;35(3):233–236.
41. Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016 Nov;31(11):2619–2631.
42. Fruzzetti F, Fidecicchi T, Benelli E, Baldari F, Tonacchera M. Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome. J Endocrinol Invest. 2024 Apr;47(4):927–936.
43. Mathew H, Castracane VD, Mantzoros C. Adipose tissue and reproductive health. Metabolism. 2018 Sep;86:18–32.
44. Skałba P, Cygal A, Madej P, et al. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):254–259.
45. Zhao H, Zhou D, Liu C, Zhang L. The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study. Int J Womens Health. 2023;15:151–166.
46. Md Muslim MZ, Mohammed Jelani A, Shafii N, Yaacob NM, Che Soh NAA, Ibrahim HA. Correlation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis. J Ovarian Res. 2024 May 18;17(1):106.
47. Fernández-Real JM, López-Bermejo A, Castro A, Casamitjana R, Ricart W. Thyroid Function Is Intrinsically Linked to Insulin Sensitivity and Endothelium-Dependent Vasodilation in Healthy Euthyroid Subjects. J Clin Endocrinol Metab. 2006 Sep 1;91(9):3337–3343.
48. Temizkan S, Balaforlou B, Ozderya A, et al. Effects of thyrotrophin, thyroid hormones and thyroid antibodies on metabolic parameters in a euthyroid population with obesity. Clin Endocrinol (Oxf). 2016 Oct;85(4):616–623.
49. Pluta W, Dudzińska W, Lubkowska A. Metabolic Obesity in People with Normal Body Weight (MONW) Review of Diagnostic Criteria. Int J Environ Res Public Health. 2022 Jan;19(2):624.
50. Huddleston HG, Quinn MM, Kao CN, Lenhart N, Rosen MP, Cedars MI. Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls. Clin Endocrinol (Oxf). 2017;87(6):775–782.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Aleksandra Misarko, Iga Woźniakowska, Maja Zambrzycka , Monika Jedwabnik, Adrianna Dobrosielska , Weronika Lech-Rzepinska, Stanisław Ścigała , Krzysztof Peszuk , Bartosz Olszewski , Hoang Viet Krajewski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 99
Number of citations: 0
